Trials / Conditions / Relapsed and/or Refractory Multiple Myeloma (RRMM)
Relapsed and/or Refractory Multiple Myeloma (RRMM)
4 registered clinical trials studyying Relapsed and/or Refractory Multiple Myeloma (RRMM) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma NCT06876142 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard NCT07222761 | Regeneron Pharmaceuticals | Phase 3 |
| Recruiting | 18F-Fluciclovine PET/CT in Multiple Myeloma NCT06103838 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myel NCT04776018 | Takeda | Phase 1 / Phase 2 |